Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 1.18 is 5985% above its 5-year average of -0.02, around the middle of its 5-year range (-4.83–4.86).
149.16% above its 12-month average of -2.40.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 0.76.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T17:51:57.753Z. Historical observations retain their original dates. Historical series through 2026-10-05.
EARNINGS PER SHARE (EPS)
1.18
EARNINGS PER SHARE (EPS) AVG TTM
-2.40
EARNINGS PER SHARE (EPS) AVG 3Y
-2.29
EARNINGS PER SHARE (EPS) AVG 5Y
-0.02
EARNINGS PER SHARE (EPS) AVG 10Y
1.49
EARNINGS PER SHARE (EPS) AVG 15Y
2.65
EARNINGS PER SHARE (EPS) AVG 20Y
2.59
CURRENT VS TTM AVG
+149.16%
CURRENT VS 3Y AVG
+151.64%
CURRENT VS 5Y AVG
+5985.29%
CURRENT VS 10Y AVG
-20.61%
CURRENT VS 15Y AVG
-55.46%
CURRENT VS 20Y AVG
-54.53%
ICU Medical, Inc.
Market Cap
$3.96B
Earnings Per Share (EPS)
1.18
TTM Avg
-2.40
3Y Avg
-2.29
5Y Avg
-0.02
Market Cap
$3.99B
Earnings Per Share (EPS)
-1.57
TTM Avg
-1.98
3Y Avg
-2.34
5Y Avg
-2.63
Market Cap
$4.02B
Earnings Per Share (EPS)
-0.54
TTM Avg
-0.52
3Y Avg
-0.25
5Y Avg
0.00
Market Cap
$4.13B
Earnings Per Share (EPS)
3.39
TTM Avg
-1.64
3Y Avg
-1.14
5Y Avg
-2.38
Market Cap
$3.75B
Earnings Per Share (EPS)
N/A
TTM Avg
-0.01
3Y Avg
-0.01
5Y Avg
-0.01
Market Cap
$4.26B
Earnings Per Share (EPS)
-1.85
TTM Avg
-1.54
3Y Avg
-1.48
5Y Avg
-1.19
Market Cap
$3.54B
Earnings Per Share (EPS)
-0.43
TTM Avg
-2.51
3Y Avg
-3.24
5Y Avg
-3.00
Market Cap
$3.53B
Earnings Per Share (EPS)
1.40
TTM Avg
0.58
3Y Avg
-0.09
5Y Avg
-0.36
Market Cap
$4.38B
Earnings Per Share (EPS)
-0.41
TTM Avg
-0.74
3Y Avg
-1.01
5Y Avg
-1.11
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ICU Medical, Inc. (ICUI) | $3.96B | 1.18 | -2.40 | -2.29 | -0.02 |
| Relay Therapeutics, Inc. (RLAY)vs › | $3.99B | -1.57 | -1.98 | -2.34 | -2.63 |
| AbCellera Biologics Inc. (ABCL)vs › | $4.02B | -0.54 | -0.52 | -0.25 | 0.00 |
| LivaNova PLC (LIVN)vs › | $4.13B | 3.39 | -1.64 | -1.14 | -2.38 |
| Regencell Bioscience Holdings Limited (RGC)vs › | $3.75B | N/A | -0.01 | -0.01 | -0.01 |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.26B | -1.85 | -1.54 | -1.48 | -1.19 |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.54B | -0.43 | -2.51 | -3.24 | -3.00 |
| Veracyte, Inc. (VCYT)vs › | $3.53B | 1.40 | 0.58 | -0.09 | -0.36 |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.38B | -0.41 | -0.74 | -1.01 | -1.11 |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.48B | -0.85 | -1.03 | -1.09 | -1.06 |
Trailing EPS (TTM)
$1.18
Forward EPS (Est.)
$8.74
P/E Ratio
134.3
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 0.03 |
| 2024-12-31 | -4.83 |
| 2023-12-31 | -1.23 |
| 2022-12-31 | -3.11 |
| 2021-12-31 | 4.86 |
| 2020-12-31 | 4.16 |
| 2019-12-31 | 4.90 |
| 2018-12-31 | 1.33 |
| 2017-12-31 | 3.50 |
| 2016-12-31 | 3.90 |
| 2015-12-31 | 2.84 |
| 2014-12-31 | 1.72 |
| 2013-12-31 | 2.75 |
| 2012-12-31 | 2.90 |
| 2011-12-31 | 3.23 |
| 2010-12-31 | 2.20 |
| 2009-12-31 | 1.80 |
| 2008-12-31 | 1.72 |
| 2007-12-31 | 1.62 |
| 2006-12-31 | 1.78 |
| 2005-12-31 | 1.47 |
| 2004-12-31 | 0.37 |
| 2003-12-31 | 1.62 |
| 2002-12-31 | 1.43 |
| 2001-12-31 | 1.20 |
| 2000-12-31 | 0.95 |
| 1999-12-31 | 0.77 |
| 1998-12-31 | 0.60 |
| 1997-12-31 | 0.47 |
| 1996-12-31 | 0.36 |
(FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown Quote observation: 2026-10-06T17:51:57.753Z. Historical observations retain their original dates. Historical series through 2022-11-07.
